Intiva Health Partners with Goldshield Technologies to Distribute Groundbreaking Disinfectant in Fight Against COVID-19

AUSTIN, Texas -- Intiva Health, creator of the innovative credentialing and compliance software Ready Doc™ for health care facilities, has entered into an exclusive agreement with Goldshield Technologies to bring the next generation of infection prevention to healthcare facilities in the Western Hemisphere.

Goldshield Technologies is the maker of proprietary anti-microbial products that actively inhibit the growth of bacteria and fungi that often cause surface deterioration and odors on surfaces for up to 90 days. In a recent study where Goldshield was applied to medical masks it was proven to eliminate COVID-19 for up to 72 hours.

To aid in the fight against COVID-19, Intiva Health evaluated dozens of products and selected the Goldshield lineup to offer medical facilities the additional protection they need against contamination due to viruses, bacteria, and hospital acquired infection (HAI).

Goldshield products have been the subject of more than 50 evidence-based studies conducted by independent laboratories, including three peer-reviewed studies in the American Journal of Infection Control.

Intiva Health seeks to improve the health of health care ranging from their Ready Doc™ credentialing software for the business side of providers' lives, to the health of facilities and those who walk the floors in them with the Goldshield Technologies line of products.

“This latest step in Intiva Health’s product offerings expands services for healthcare organizations beyond the security of medical documents and administration efficiency to help protect patients, providers, and the overall safety of the facility,” said Dr. Ayan Monpara, Chief Medical Officer with Intiva Health.

Goldshield's surface and textile products are EPA-approved for a wide variety of applications, including hospitals, senior living facilities, private practices, and anywhere health care is provided while their alcohol-free hand sanitizer and protectant is FDA-registered.

“Intiva Health has an excellent management team, a vast understanding of healthcare challenges and an expansive reach into this sector,” said Thomas l. Higgins, CEO of Goldshield Technologies. “As we focus on building solution-based technologies, such as applying Goldshield to PPE, we are delighted to partner with Intiva for the distribution of an important product at a crucial time."
The killing action of the new anti-microbial technology is different than traditional disinfectants. Most disinfectants encapsulate microorganisms, releasing bacteria-killing chemicals into the cells. Goldshield has a long carbon chain, like a bed of nails, that releases an ionic charge that destroys the cell structure.

Goldshield can be applied by commercial pressure sprayer or pump-sprayer to most surfaces including bed railings, privacy curtains, air filters and equipment. It forms a strong chemical bond that will not leach off, and it remains on the surface even through subsequent cleanings. The water-based formulation poses no respiratory or contact risk.
A recent study found Goldshield creates a bio barrier successful in eliminating the SARS-CoV-2 (COVID-19) virus on treated personal protective equipment (PPE) such as medical masks and medical gloves for up to 72 hours. Regulatory approvals are being sought on this product for the USA.

Media Contact:
Joshua Kleinstreuer
Intiva Health Media Relations and Content Coordinator
1701 Directors Blvd. #110
Austin, Texas 78744

About Intiva Health:

Intiva Health is improving the health of health care with products for facilities, providers, and patients. Their software Ready Doc™ is the first and only free credentialing software that uses distributed ledger technology to create the most secure solution available on the market. Health care organizations and providers use the software to expedite the credentialing process, saving the industry significant time and money while reducing risk. The company is headquartered in Austin, Texas.

Visit IntivaHealth.com for more information or call 844.413.2602.

This release was published on openPR.